SMARCA1 and breast carcinoma: Exon inclusion in SPPL2A and exon exclusion in SMARCA1 were observed not only in LADC, but also in MDA-MB-231 cells, a breast cancer cell line with a truncating CMTR2 mutation (Supplementary Fig. 13a, b and Supplementary Table 5).